Gilead Sciences Inc. (GILD) recently announced that its Marketing Authorisation Application (MAA) for HCV candidate sofosbuvir (formerly GS-7977),... ...

Athersys, Inc.'s (ATHX) first quarter 2013 adjusted net loss of 13 cents per share was wider than the Zacks Consensus Estimate of a loss of 10... ...

Shares of Celgene Corporation (CELG) hit a 52-week high of $131.13 in the first half of the trading session on May 13. This biopharmaceutical stock... ...

Endo Health Solutions Inc. (ENDP) recently suffered a setback with the US Food and Drug Administration (FDA) turning down its request to prevent... ...

Warner Chilcott's (WCRX) first quarter 2013 earnings (excluding special items) of 92 cents per share handsomely beat the Zacks Consensus Estimate... ...

Top Coverage News